Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colloidal Oatmeal Cream for Atopic Dermatitis in Infants and Toddlers
NCT02120833Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Mar 2014
- Primary completion
- Nov 2014
- Modality
- Emollient, Cosmetic
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of colloidal oatmeal cream in atopic dermatitis (AD) (2 arms), sponsored by Johnson & Johnson. Primary endpoints: Eczema Area and Severity Index at Day 3 and Investigator's Global Atopic Dermatitis Assessment at Day 3. Started Mar 2014; status: completed.
02
Drugs
colloidal oatmeal cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02120833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120833.